ANNA GORELIK: Open Payments
NPI 1407139801 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,076 in 96 payments from 25 companies in 2025. Trend: 2023 $2,942 · 2024 $2,486 · 2025 $4,076
Food & beverage: $2,357Consulting: $1,344Education: $375
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 2 | $1,344 |
| GENZYME CORPORATION | 8 | $369 |
| AstraZeneca Pharmaceuticals LP | 10 | $335 |
| HARMONY BIOSCIENCES LLC | 9 | $282 |
| Viatris Specialty LLC | 13 | $221 |
| Verona Pharma, Inc. | 8 | $217 |
| Regeneron Healthcare Solutions, Inc. | 4 | $208 |
| GlaxoSmithKline, LLC. | 7 | $162 |
| Actelion Pharmaceuticals US, Inc. | 2 | $123 |
| Insmed, Inc. | 5 | $112 |
Products named: DUPIXENT, YUPELRI, WAKIX, Ohtuvayre, TEZSPIRE, TRELEGY ELLIPTA, OPSUMIT, Prolastin-C Liquid.
Industry payments across NY — which companies pay providers there.
